DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



I-Beam and Cruciate Tibial Components Used in Total Knee Replacement

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Degenerative Arthritis; Osteoarthritis; Rheumatoid Arthritis; Knee Arthritis

Intervention: I-beam design (Device); Cruciate design (Device)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Biomet Orthopedics, Inc.

Summary

The purpose of this study is to compare the clinical outcomes of using an I-beam or cruciate tibial component in total knee replacement.

Clinical Details

Study design: Cohort, Prospective

Primary outcome: Revision rate

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with painful and disabled knee joint resulting from osteoarthritis,

rheumatoid arthritis, traumatic arthritis where one or more compartment are involved.

- Patients requiring correction of varus, valgus, or posttraumatic deformity

- Patients requiring correction of revision of unsuccessful osteotomy, arthrodesis, or

failure of previous joint replacement procedure.

Exclusion Criteria:

- Patients with infection, sepsis, or osteomyelitis.

Locations and Contacts

Biomet Orthopedics, Inc., Warsaw, Indiana 46581, United States
Additional Information

Starting date: August 2006
Ending date: September 2017
Last updated: January 7, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009